Core Viewpoint - The article highlights the significant transformations and future directions of the scientific instrument industry in 2025, emphasizing the impact of geopolitical tensions, domestic innovation, and regulatory changes on the sector's development [3]. Group 1: U.S. Export Ban - In early 2025, the U.S. Department of Commerce issued a ban on the export of high-parameter flow cytometers and high-end mass spectrometry equipment to China, citing concerns that the data generated could aid China's AI and biotechnology advancements [5]. - This ban has intensified calls for domestic alternatives, raising questions about the capabilities of Chinese scientific instrument companies to match international standards [5]. - The pressure from the ban has accelerated technological advancements among leading domestic firms, highlighting the necessity for self-reliance in core technologies [5]. Group 2: Trade War 2.0 - The trade war between the U.S. and China re-emerged in 2025, with tariffs exceeding 145% at one point, leading to a series of negotiations that resulted in a temporary ceasefire by the end of October [6]. - China has adopted proactive measures in response, including placing U.S. entities on an unreliable entity list and initiating anti-dumping investigations against U.S. medical CT tubes [6]. - The trade conflict has prompted significant advancements in domestic instrument capabilities, allowing some Chinese brands to compete effectively in specific niches [6]. Group 3: "Domestic Product" Standards - Starting January 1, 2026, the government will implement "domestic product standards" for procurement, providing a clear definition of what constitutes a domestic product [8]. - The new standards will offer a 20% price evaluation advantage for qualifying domestic products, promoting both domestic and foreign companies that meet the criteria [8]. - This policy is expected to accelerate R&D investments by domestic firms and encourage foreign companies to localize their operations to adapt to the new standards [9]. Group 4: "14th Five-Year Plan" and "15th Five-Year Plan" - The "15th Five-Year Plan" emphasizes high-end scientific instruments as a key area for breakthroughs, advocating for a comprehensive approach that spans from foundational theory to application [10]. - Local governments are aligning their plans with national priorities, focusing on high-end instruments and core technology breakthroughs [10]. - The next five years are projected to be critical for the continuous advancement and self-reliance of China's scientific instrument industry [10]. Group 5: First Sets of Major Technical Equipment - The concept of "first sets of major technical equipment" refers to domestically developed equipment that has achieved significant technological advancements and is recognized for its potential [12]. - In 2025, several domestic mass spectrometer manufacturers were recognized for their innovations, marking a significant step in the industry [12]. - Policies supporting the demonstration and application of these first sets have been established, providing financial incentives and recognition to promote domestic breakthroughs [12]. Group 6: Instrument Aftermarket - The demand for services in the instrument aftermarket is rapidly increasing due to a growing user base and the aging of existing equipment [13]. - The trade tensions have led to a surge in the second-hand instrument market, with a 62% increase in transaction volume following tariff hikes [13]. - The aftermarket is evolving from a cost center to a profit center, with new business models like second-hand sales and equipment leasing driving growth [13]. Group 7: Biotechnology and Seed Industry - The biotechnology sector, particularly in seed development, has been highlighted as a critical area for national food security, with significant investments in research and development [14][15]. - The establishment of high-level research institutions and laboratories across various provinces is aimed at fostering innovation in the seed industry [15]. - Scientific instruments play a vital role in supporting the development and application of biotechnological advancements in agriculture [15]. Group 8: 2025 Edition of the Pharmacopoeia - The 2025 edition of the Chinese Pharmacopoeia is set to significantly influence laboratory practices and instrument development, with stricter requirements for testing methods and quality control [16]. - The introduction of advanced analytical techniques in the new pharmacopoeia presents both challenges and opportunities for instrument manufacturers [16]. - The revisions are expected to drive innovation and improvements in the capabilities of analytical instruments [16]. Group 9: AI and Instruments - The year 2025 is seen as a breakthrough year for AI applications, with significant integration of AI technologies into the scientific instrument sector [17][18]. - The industry is shifting from a cautious approach to actively exploring AI's potential to enhance instrument performance and expand application areas [17]. - The challenge remains to convert AI's disruptive potential into tangible innovations that drive high-quality development in the industry [18]. Group 10: National Team of Scientific Instruments - The trend of state-owned enterprises investing in the scientific instrument sector has become more pronounced in 2025, with several significant partnerships and investments announced [19][20]. - This collaboration between state capital and independent research is seen as a pathway for domestic alternatives to gain traction in the market [19]. - National industrial clusters are emerging, enhancing collaborative capabilities and supporting the industry's self-reliance and technological advancements [20].

Investment Rating - The report initiates coverage with an "Accumulate" rating for the company [2][8] Core Insights - The company is a leading domestic CMP polishing liquid enterprise, continuously expanding its second growth curve through diversified product offerings [7][16] - The semiconductor industry is entering a prosperous cycle, with significant capacity expansion among wafer fabs, benefiting material suppliers [7][52] - The company maintains a strong focus on R&D and innovation, with a robust "3+1" technology platform that supports its core business in polishing liquids and expands into functional wet chemicals and electroplating solutions [7][8] Financial Data and Profit Forecast - Projected total revenue for 2024 is 1,835 million yuan, with a year-on-year growth rate of 48.2%. For 2025, the expected revenue is 2,506 million yuan, reflecting a growth rate of 36.6% [5] - The company's net profit attributable to shareholders is forecasted to be 534 million yuan in 2024, increasing to 811 million yuan in 2025, with a year-on-year growth rate of 52.1% [5] - The gross margin is expected to stabilize around 56.8% for 2025, with a return on equity (ROE) projected at 24.2% [5][8] Market Position and Growth Drivers - The company has achieved a global market share of over 10% in CMP polishing liquids, with significant growth in functional wet chemicals and electroplating solutions [7][8] - The demand for CMP polishing liquids is driven by advancements in integrated circuit technology, leading to increased usage and value of polishing materials [7][52] - The company is strategically positioned in the largest semiconductor material markets, namely Taiwan and mainland China, enhancing its competitive advantage [7][44] Product and Technology Development - The company has developed a comprehensive product matrix in CMP polishing liquids, functional wet chemicals, and electroplating solutions, catering to various semiconductor manufacturing processes [16][19] - Continuous R&D investment has led to a stable increase in the number of patents, with a focus on high-end differentiated products in the functional wet chemical segment [38][44] Future Outlook - The company is expected to see net profits of 8.11 billion yuan, 10.21 billion yuan, and 12.74 billion yuan from 2025 to 2027, with corresponding price-to-earnings ratios of 45, 36, and 29 [8][9] - The ongoing expansion of domestic semiconductor manufacturing capacity, particularly among leading firms, is anticipated to further benefit the company [52][56]

Core Viewpoint - The A-share market in 2025 saw significant growth across various sectors, with the top ten sectors experiencing substantial annual increases driven by factors such as AI demand, technological advancements, and geopolitical tensions [1][2] Group 1: Sector Performance - The top-performing sectors in 2025 included: - Optical Communication Modules with a growth of 156.02% - F5G Concept with a growth of 128.33% - CPO Concept with a growth of 124.50% - Space Station Concept with a growth of 115.95% - PCB with a growth of 112.11% - Foxconn with a growth of 111.69% - Nvidia Concept with a growth of 104.45% - Gold Concept with a growth of 97.35% - Robotics with a growth of 86.54% - New Industrialization with a growth of 83.86% [1][2] Group 2: Drivers of Growth - The surge in Optical Communication Modules and CPO Concept was primarily driven by: - Explosive demand for AI computing power - Accelerated technological iterations - Domestic substitution and policy funding support [1] - The growth in PCB, Foxconn, and Nvidia Concept was attributed to: - Explosive growth in AI computing demand - Increased production and sales of high-end products due to AI servers - Resonance with demand from new energy vehicles and consumer electronics, leading to record-high industry performance [1] - The significant rise in the Gold Concept was driven by: - The onset of the Federal Reserve's interest rate cuts, which lowered real interest rates and weakened the dollar - Escalating global geopolitical conflicts and ongoing central bank gold purchases, alongside a trend towards de-dollarization, creating a demand for safe-haven assets [1]

Core Insights - The A-share market experienced significant growth in 2025, with the Shanghai Composite Index returning to 4000 points for the first time in ten years and total trading volume exceeding 410 trillion yuan, reflecting a record high in market capitalization [1][9]. Market Performance - The Shanghai Composite Index rose by 18.30%, the Shenzhen Component Index increased by 30.62%, and the ChiNext Index surged by 51.42% throughout the year [9]. - Nearly 500 stocks doubled in value, marking an increase of over 460% compared to 2024, indicating heightened market enthusiasm and growth [9]. Sector Performance - The market exhibited a "structural market" where funds were concentrated in sectors with strong growth certainty, rather than a broad-based rally [10]. - The top three performing sectors were: - Non-ferrous metals with a 92.64% increase - Communication sector with an 87.27% rise - Electronics sector with a 49.40% growth [10]. Non-Ferrous Metals - The non-ferrous metals sector led the market with a 92.64% increase, driven by global liquidity, supply constraints, and surging demand from new energy and AI sectors [11]. - Related products, such as rare metal ETFs, also saw significant gains, with a rare metal ETF rising by 89.16% and net inflows of 1.704 billion yuan [11]. Communication Sector - The communication sector achieved an 87.27% annual increase, supported by ongoing 5G construction and strong demand for AI computing power [12]. - A communication ETF rose by 85.08%, reflecting investor confidence in the sector's long-term value [12]. Electronics and Chips - The electronics sector grew by 49.40%, bolstered by AI computing and domestic semiconductor production [13]. - The Sci-Tech Chip Index surged by 63.41%, with a chip ETF reaching a scale of 39.6 billion yuan and net inflows of 2.621 billion yuan [13]. Power Equipment - The power equipment sector increased by 43.12%, driven by the "dual carbon" goals and investment in energy transition technologies [15]. - A battery ETF rose by 70.61%, with a scale of 1.465 billion yuan and net inflows of 779 million yuan [15]. Machinery Equipment - The machinery equipment sector saw a 41.83% increase, with a focus on smart manufacturing and industrial robots [16]. - A robotics ETF rose by 31.03%, indicating market optimism towards advanced robotics [16]. Future Outlook - The structural opportunities in high-growth sectors are expected to continue, driven by the rapid expansion of AI infrastructure, ongoing energy transitions, and strategic layouts in high-end manufacturing [16].

Core Viewpoint - The Hong Kong stock market's Hang Seng Technology Index achieved a remarkable annual increase of 23.45% in 2025, marking its best performance since 2020, with 22 out of 30 constituent stocks rising [1] Group 1: Stock Performance - Among the 30 constituent stocks, notable performers included Hua Hong Semiconductor, which surged by 243.19%, Horizon Robotics with a rise of 140.56%, and SMIC increasing by 124.69% [1] - Other significant gainers were JD Health at 97.51%, Alibaba-W at 77.50%, Xpeng Motors-W at 70.10%, Baidu Group-SW at 59.01%, and Tencent Music-SW at 58.44% [1][2] Group 2: Investment Preferences - The first tier of investment preference is in semiconductor manufacturing (Hua Hong, SMIC) and core AI chips (Horizon Robotics), reflecting a strong focus on hard technology and domestic substitution logic [1] - The second tier includes growth sectors such as smart electric vehicles (Xpeng, Li Auto), AI applications (Baidu, SenseTime), and digital health (JD Health), which benefit from industry trends but still face competitive and profitability uncertainties [1] - The third tier consists of value recovery in platform internet giants (Alibaba, Tencent) and mature applications (NetEase, Kuaishou, Tencent Music), with gains primarily driven by profit realization and value reassessment through dividends and buybacks, categorized as "high-quality mature assets" [1]

Group 1 - The core viewpoint of the article is that the dual innovation sector (Science and Technology Innovation Board + Growth Enterprise Market) has become a shining main line in the domestic market, with the Science and Technology Innovation 50 Index showing remarkable performance in 2025, and there are expectations for new opportunities in 2026 [1][8] Group 2 - In 2025, the dual innovation sector emerged as a core force driving the growth style of A-shares, with the Science and Technology Innovation 50 Index achieving an annual increase of 64.32%, significantly outperforming major indices like CSI 300 (18.21%) and CSI 500 (22.78%) [2][5] - The trading volume of the Science and Technology Innovation 50 Index increased by 120.68% compared to 2024, indicating strong market recognition of hard technology core assets [2][5] Group 3 - The excellent performance of the dual innovation sector in 2025 can be attributed to several factors: 1. An upward industrial cycle and improved profitability, with technology breakthroughs and performance landing in hard technology sectors creating a virtuous cycle [5] 2. A relatively loose funding environment, enhanced by the Federal Reserve's interest rate cuts, which increased risk appetite for growth-style investments [5] 3. Policy dividends supporting the deepening of the technology-driven national strategy, with the "14th Five-Year Plan" promoting self-reliance in technology benefiting key industries like semiconductors and AI [5][8] Group 4 - For 2026, the dual innovation sector is expected to benefit from a dual drive of policy and industrial upgrades, with key focus areas including: 1. The domestic substitution and profitability realization of the AI industry chain, driven by the continuous expansion of AI applications and increasing semiconductor demand [9] 2. Supply-demand optimization and profitability improvement in industries like photovoltaics and power batteries, as "anti-involution" policies aim to correct vicious competition and promote structural reforms [12] Group 5 - The Science and Technology Innovation 50 Index, which includes 50 major strategic emerging companies from the Science and Technology Innovation Board and Growth Enterprise Market, covers nearly 90% of the electronic, power equipment, pharmaceutical, and communication sectors, providing a balanced exposure to core growth sectors [13] - The E Fund Science and Technology Innovation ETF (159781) is highlighted as a convenient tool for investors to track the index performance and capture the benefits of new productive forces and technological advancements, with a current scale of 11.99 billion [13]

Investment Rating - The report assigns an "Accumulate" rating for the company, marking its first coverage [3][7]. Core Insights - The company is positioned as a high-growth player in the hardware industry, leveraging cost reduction and brand strength to create "high-end cost performance" [1]. - The company has achieved a compound annual growth rate (CAGR) of 29% in revenue and 59% in net profit from 2019 to 2024, showcasing its robust growth even in a challenging real estate environment [9][47]. - The growth sources are analyzed from three perspectives: product strategy focusing on cost reduction and popular products, channel expansion through offline and online sales, and a market strategy that emphasizes high-end cost performance [9][10][48]. Financial Data and Profit Forecast - Total revenue is projected to reach 35.95 billion yuan in 2025, with a net profit of 7.06 billion yuan, corresponding to a price-to-earnings (PE) ratio of 33 [2][7]. - The company expects to maintain a steady growth trajectory, with revenue forecasts of 45.25 billion yuan in 2026 and 56.53 billion yuan in 2027, alongside net profits of 9.42 billion yuan and 12.37 billion yuan respectively [2][7]. - The gross margin is anticipated to improve from 37.8% in 2025 to 39.7% in 2027, reflecting ongoing cost control and efficiency improvements [2]. Growth Drivers - The company’s growth is driven by its ability to reduce costs through increased self-production and a high proportion of standard parts, which enhances operational efficiency [10][55]. - The product mix includes a strong focus on basic hardware, which has seen a CAGR of 64% from 2019 to 2024, significantly contributing to revenue growth [48]. - The company has successfully transitioned from increasing the number of distributors to enhancing the quality of existing distributors, leading to substantial growth in single-store sales [9][10]. Market Positioning - The company adopts a "high-end cost performance" strategy, effectively competing against foreign brands and private labels, thus capturing market share from both segments [9][10]. - The brand has received multiple prestigious design awards, enhancing its competitive edge in the hardware sector [9][10]. Production Capacity and Efficiency - The company has significantly increased its production capacity, with plans for a new facility expected to enhance its ability to produce core components like hinges and guides [55][61]. - The implementation of automated production processes has led to a substantial increase in output per employee, particularly in basic hardware [63]. Research and Development - R&D expenditures have risen from 29 million yuan in 2019 to 111 million yuan in 2024, indicating a commitment to innovation and product development [42][45].

Core Insights - The Hong Kong stock market closed 2025 with the Hang Seng Index rising by 27.77%, marking its best annual performance since 2017 [1] - Among the constituents of the Hang Seng Index, China Hongqiao surged by 203.72%, leading the gains, followed by Zijin Mining at 162.29%, and SMIC at 124.69% [1][2] Group 1: Performance Highlights - China Hongqiao's stock price reached 32.620 with a year-to-date increase of 203.72% [2] - Zijin Mining's stock price was 35.660, reflecting a year-to-date rise of 162.29% [2] - SMIC's stock price stood at 71.450, with a year-to-date increase of 124.69% [2] - Hansoh Pharmaceutical increased by 113.33% year-to-date, with a stock price of 36.080 [2] - Pop Mart's stock price was 37.700, showing a year-to-date rise of 111.46% [2] - Innovent Biologics saw a year-to-date increase of 108.33%, with a stock price of 76.250 [2] - Chow Tai Fook's stock price was 12.390, reflecting a year-to-date increase of 100.16% [2] - China Biologic Products had a stock price of 6.180, with a year-to-date rise of 98.71% [2] - JD Health's stock price was 55.500, showing a year-to-date increase of 97.51% [2] - China Life's stock price stood at 27.380, with a year-to-date increase of 96.60% [2] Group 2: Sector Analysis - The performance of the top stocks reflects four main themes: cyclical resources, hard technology, innovative pharmaceuticals, and niche consumption [1] - Stocks like China Hongqiao and Zijin Mining benefited from global inflation and industrial demand [1] - SMIC represents the core of domestic substitution and technological self-reliance [1] - Companies like Hansoh and Innovent are being valued for genuine innovation and international pricing [1] - Niche consumption sectors, represented by Pop Mart, Chow Tai Fook, and JD Health, demonstrate strong vitality even in a weak recovery environment [1]

Core Viewpoint - New Guangyi (301687.SZ), a leading company in specialty membranes, has been well-received in the market upon its listing, with a peak increase of 285% and a transaction amount exceeding 1 billion yuan. The company raised 638 million yuan for functional material project development, highlighting its strong market position and growth potential in high-performance specialty materials [2]. Group 1: Company Overview - New Guangyi specializes in high-performance specialty materials, particularly anti-overflow adhesive membranes and strong resistance specialty membranes, holding a monopoly in the niche market of anti-overflow adhesive membranes. The company has established deep partnerships with several top global flexible printed circuit board (FPC) manufacturers [2][3]. - Since its establishment in 2004, New Guangyi has transitioned from general functional adhesive films to focusing on specialty membrane materials for FPC core processes, breaking the technological monopoly of foreign companies in high-end FPC materials [3]. Group 2: Technological Advancements - The company has developed a comprehensive technical system with 15 core technologies across five categories, including raw material synthesis and coating process technology, which has created a significant technological moat [3][4]. - Innovations in the casting process have improved the uniformity of membrane thickness to micron-level precision, and the melt blending control technology allows for repeated use of products at high temperatures without performance degradation [4][6]. Group 3: Financial Performance - New Guangyi exhibits characteristics of a "small but beautiful" enterprise, achieving high profitability and asset return rates despite a smaller revenue scale. The gross profit margins for core products have shown a steady increase from 31.76% in 2022 to 32.44% in Q3 2025 [8][9]. - The company has a net asset return rate (ROE) of 13.88% as of September 30, 2025, significantly outperforming competitors, indicating strong financial health and operational efficiency [9]. Group 4: Market Position and Client Relationships - New Guangyi has established a solid position in the supply chain, being recognized as a core supplier by major FPC manufacturers and receiving multiple awards for its contributions [7][8]. - The company has optimized its customer structure, reducing reliance on its top five clients from 69.64% in 2022 to 52.88% in 2024, which enhances its stability and reduces risks associated with customer concentration [12][13]. Group 5: Future Growth Prospects - The functional membrane materials market in China is expected to grow rapidly, driven by demand in new display, renewable energy, and environmental protection sectors. New Guangyi has begun to expand into the renewable energy materials sector, with a revenue contribution of 12.59% in the first nine months of 2025 [13][14]. - The synergy between new energy materials and existing strong resistance specialty membranes allows for efficient resource utilization and lower marginal production costs, indicating significant growth potential for the company [14][15].

来源：纪要逻辑社 Q：长存公司近期盈利表现如何？盈利大幅改善 的核心驱动因素是什么？ A：长存公司近期盈利实现显著提升，核心驱动因素是行业景气周期下产品价格的大幅上调，推 动毛利 率和净利润快速增长。具体来看，25年 Q3毛利率已达38%，Q4预估可进一步攀升至 47%，距离海外龙 头50%-60%的水平仅一步之遥。同时，严格的成本管控和上半年资本支出缩 减带来的折旧优势，也为 盈利改善提供了支撑。 尽管前三季度净利仍亏损19.6亿，但招股书预测 全年将实现20-30亿利润，其中 25年Q4单季利润 预期高达70-80亿，产品成本刚性使得所有涨价都能直接转化为利润。 Q：长存公司未来业绩增长的核心动力有哪些？ 全球存储市场格局对其有何影响？ A：长存公司未来业绩增长主要依赖两大动力： 一是加速扩产以匹配市场需求，应对全球存储供 需紧 张的格局；二是客户构成多样化，目前服务器业务收入占比已从个位数跃升20%-30%，业 务结构实现 重大转变。从行业环境来看，市场分析认为未来三年全球存储供需或将持续紧张，这 一格局将支撑存 储产品价格持续看涨，为公司业绩增长提供有力支撑。此外，AI服务器需求激 增，叠加三星、美光 ...